ProQR Therapeutics N.V. Current Liabilities
ProQR Therapeutics N.V. (PRQR) had Current Liabilities of EUR 32.44 million as of 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2026-03-12
- 2025-12-31: Current Liabilities 32.44M EUR.
- 2025-09-30: Current Liabilities 33.14M EUR.
- 2025-06-30: Current Liabilities 33.09M EUR.
- 2025-03-31: Current Liabilities 33.72M EUR.
| Period end | Current Liabilities | Current Liabilities as first filed |
|---|---|---|
| 2025-12-31 | 32.44M EUR 20-F · filed 2026-03-12 | |
| 2025-09-30 | 33.14M EUR 6-K · filed 2025-11-06 | |
| 2025-06-30 | 33.09M EUR 6-K · filed 2025-08-07 | |
| 2025-03-31 | 33.72M EUR 6-K · filed 2025-05-08 | |
| 2024-12-31 | 38.90M EUR 20-F · filed 2026-03-12 | |
| 2024-09-30 | 39.64M EUR 6-K · filed 2024-11-07 | |
| 2024-06-30 | 37.28M EUR 6-K · filed 2024-08-08 | |
| 2024-03-31 | 34.42M EUR 6-K · filed 2024-05-09 | |
| 2023-12-31 | 34.20M EUR 20-F · filed 2025-03-13 | |
| 2023-09-30 | 26.65M EUR 6-K · filed 2023-11-07 | |
| 2023-06-30 | 22.98M EUR 6-K · filed 2023-08-03 | |
| 2023-03-31 | 17.16M EUR 6-K · filed 2023-05-16 | |
| 2022-12-31 | 20.99M EUR 20-F · filed 2024-03-13 | 21.11M EUR 20-F · filed 2023-03-29 |
| 2022-09-30 | 26.97M EUR 6-K · filed 2022-11-09 | |
| 2022-06-30 | 27.14M EUR 6-K · filed 2022-08-04 | |
| 2022-03-31 | 23.71M EUR 6-K · filed 2022-05-05 | |
| 2021-12-31 | 27.60M EUR 20-F · filed 2023-03-29 | |
| 2021-09-30 | 34.69M EUR 6-K · filed 2021-11-04 | |
| 2021-06-30 | 12.37M EUR 6-K · filed 2021-08-05 | |
| 2020-12-31 | 10.30M EUR 20-F · filed 2022-04-29 | |
| 2020-09-30 | 10.82M EUR 6-K · filed 2020-11-16 | |
| 2020-06-30 | 9.03M EUR 6-K · filed 2020-08-06 | |
| 2020-03-31 | 9.15M EUR 6-K · filed 2020-05-07 | |
| 2019-12-31 | 10.99M EUR 20-F · filed 2021-03-24 | |
| 2019-09-30 | 11.13M EUR 6-K · filed 2019-11-12 | |
| 2019-06-30 | 9.05M EUR 6-K · filed 2019-08-07 | |
| 2018-12-31 | 8.16M EUR 20-F · filed 2020-03-31 | |
| 2018-06-30 | 8.79M EUR 6-K · filed 2018-08-08 | |
| 2017-12-31 | 8.49M EUR 20-F · filed 2019-03-28 | |
| 2016-12-31 | 6.71M EUR 20-F · filed 2018-03-30 |